Publicaciones en colaboración con investigadores/as de University of Birmingham (10)

2022

  1. Phase I/II Multicenter Trial of a Novel Therapeutic Cancer Vaccine, HepaVac-101, for Hepatocellular Carcinoma

    Clinical Cancer Research, Vol. 28, Núm. 12, pp. 2555-2566

  2. The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality

    The Lancet, Vol. 399, Núm. 10319, pp. 61-116

2020

  1. Mortality prediction in chronic obstructive pulmonary disease comparing the gold 2015 and gold 2019 staging: A pooled analysis of individual patient data

    ERJ Open Research, Vol. 6, Núm. 4, pp. 1-10

2019

  1. Corrigendum to “New vaccination strategies in liver cancer” [Cytokine Growth Factor Rev. 36 (2017) 125–129](S1359610117301089)(10.1016/j.cytogfr.2017.06.010)

    Cytokine and Growth Factor Reviews

  2. External Validation and Recalculation of the CODEX Index in COPD Patients. A 3CIAplus Cohort Study

    COPD: Journal of Chronic Obstructive Pulmonary Disease

  3. Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma

    Genome Medicine, Vol. 11, Núm. 1

2018

  1. Large-scale external validation and comparison of prognostic models: An application to chronic obstructive pulmonary disease

    BMC Medicine, Vol. 16, Núm. 1

2016

  1. Long-term impact of liver function on curative therapy for hepatocellular carcinoma: Application of the ALBI grade

    British Journal of Cancer, Vol. 114, Núm. 7, pp. 744-750

2015

  1. A nssessment of liver function in patients with hepatocellular carcinoma: A new evidence-based approach - The albi grade

    Journal of Clinical Oncology, Vol. 33, Núm. 6, pp. 550-558

2008

  1. Comparison of molecular strategies for breast cancer virotherapy using oncolytic adenovirus

    Human Gene Therapy, Vol. 19, Núm. 9, pp. 873-886